| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Diethylnitrosamine] results in increased expression of and affects the localization of YAP1 protein" | 21391223 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of YAP1 protein" | 21391223 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "YAP1 protein modified form results in increased susceptibility to 1,4-bis(2-(3,5-dichloropyridyloxy))benzene" | 21391223 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of YAP1 mRNA" | 20816883 |
| C583074 | 4,4'-hexafluorisopropylidene diphenol | "4,4'-hexafluorisopropylidene diphenol results in increased expression of YAP1 mRNA" | 25912373 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of YAP1 mRNA | 21420995 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of YAP1 mRNA | 22100608 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of YAP1 mRNA | 24449571 |
| D001151 | Arsenic | Arsenic affects the localization of YAP1 protein | 23942117 |
| D001151 | Arsenic | Arsenic results in increased expression of and results in decreased phosphorylation of YAP1 protein | 23942117 |
| D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of YAP1 mRNA" | 18687144 |
| C487081 | belinostat | belinostat results in decreased expression of and results in decreased phosphorylation of YAP1 protein | 23671600 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of YAP1 mRNA | 20106945 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YAP1 mRNA" | 19150397 |
| D004958 | Estradiol | Estradiol affects the expression of YAP1 mRNA | 22574217 |
| C006780 | bisphenol A | bisphenol A results in increased expression of YAP1 mRNA | 26063408 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of YAP1 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of YAP1 gene | 28505145 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA | 28628672 |
| C013418 | bromfenacoum | bromfenacoum results in decreased expression of YAP1 protein | 28903499 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of YAP1 mRNA | 25979313 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene | 20938992 |
| C031180 | chrysene | chrysene results in increased expression of YAP1 mRNA | 26377693 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of YAP1 mRNA | 19549813 |
| D003471 | Cuprizone | Cuprizone affects the expression of YAP1 mRNA | 27523638 |
| D003513 | Cycloheximide | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA | 19684285 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA | 28628672 |
| D016264 | Dextran Sulfate | [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased phosphorylation of and affects the localization of YAP1 protein | 24146755 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of YAP1 mRNA | 17361019 |
| D002945 | Cisplatin | "[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein" | 21214929 |
| D002945 | Cisplatin | [Cisplatin results in increased expression of MIR630] which results in decreased expression of YAP1 mRNA | 21274007 |
| D002945 | Cisplatin | Cisplatin results in increased expression of YAP1 protein modified form | 21214929 |
| D002945 | Cisplatin | wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form] | 21214929 |
| D002945 | Cisplatin | YAP1 protein inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] | 20947521 |
| D002945 | Cisplatin | YAP1 protein inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein] | 20947521 |
| D002945 | Cisplatin | "YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| D002945 | Cisplatin | "[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D002945 | Cisplatin | YAP1 protein results in increased susceptibility to Cisplatin | 20729916 |
| D002945 | Cisplatin | YAP1 results in decreased susceptibility to Cisplatin | 20947521 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of and results in decreased activity of YAP1 protein | 24147051 |
| D004041 | Dietary Fats | [Dietary Fats results in decreased expression of and results in decreased activity of YAP1 protein] which results in decreased expression of PENK protein alternative form | 24147051 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of YAP1 mRNA | 24147051 |
| D004052 | Diethylnitrosamine | "[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Diethylnitrosamine] results in increased expression of and affects the localization of YAP1 protein" | 21391223 |
| D004317 | Doxorubicin | "[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein" | 21214929 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of YAP1 protein modified form | 21214929 |
| D004317 | Doxorubicin | wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form] | 21214929 |
| D004317 | Doxorubicin | "YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein" | 21214929 |
| D004317 | Doxorubicin | "[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein" | 21214929 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of YAP1 mRNA | 23649840 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene | 20938992 |
| D004397 | Fonofos | Fonofos results in increased methylation of YAP1 promoter | 22847954 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of YAP1 mRNA | 23649840 |
| C039281 | furan | furan results in increased expression of YAP1 protein | 27371368 |
| C056507 | gemcitabine | SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to gemcitabine]] | 26894857 |
| C056507 | gemcitabine | YAP1 protein affects the reaction [gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein] | 26894857 |
| C056507 | gemcitabine | YAP1 protein affects the reaction [gemcitabine results in increased cleavage of PARP1 protein] | 26894857 |
| C056507 | gemcitabine | YAP1 protein affects the susceptibility to gemcitabine | 26894857 |
| C056507 | gemcitabine | YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to gemcitabine] | 26894857 |
| D005947 | Glucose | [INS protein co-treated with Glucose] results in increased expression of YAP1 mRNA | 22634610 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA | 28628672 |
| C057531 | jasplakinolide | jasplakinolide results in decreased phosphorylation of and affects the localization of YAP1 protein | 24040060 |
| C057531 | jasplakinolide | YAP1 protein affects the reaction [jasplakinolide results in increased expression of CTGF protein] | 24040060 |
| C057531 | jasplakinolide | YAP1 protein affects the reaction [jasplakinolide results in increased expression of CYR61 protein] | 24040060 |
| D048628 | Ketolides | Ketolides analog results in decreased expression of YAP1 mRNA | 24967691 |
| C008261 | lead acetate | lead acetate affects the expression of YAP1 mRNA | 21864555 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of YAP1 mRNA | 28001369 |
| C000621033 | napabucasin | napabucasin results in decreased expression of YAP1 mRNA | 25605917 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of YAP1 mRNA | 26272509 |
| D010261 | Paraoxon | Paraoxon results in decreased expression of YAP1 mRNA | 24413757 |
| D010278 | Parathion | Parathion results in increased methylation of YAP1 promoter | 22847954 |
| C568608 | PCI 5002 | [PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA | 18593933 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of YAP1 mRNA | 23892564 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of YAP1 mRNA | 26272509 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of YAP1 mRNA | 27029645 |
| D011794 | Quercetin | Quercetin results in decreased expression of YAP1 mRNA | 21632981 |
| C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in decreased expression of YAP1 mRNA | 21427059 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of YAP1 mRNA | 28595984 |
| C012568 | terbufos | terbufos results in increased methylation of YAP1 promoter | 22847954 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA | 19684285 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of YAP1 mRNA | 19684285 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of YAP1 mRNA | 21570461 |
| D013806 | Theophylline | Theophylline results in decreased expression of YAP1 mRNA | 18951874 |
| C009495 | titanium dioxide | titanium dioxide affects the expression of YAP1 mRNA | 17656681 |
| D014241 | Trichloroethylene | Trichloroethylene results in decreased expression of YAP1 mRNA | 19448997 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of YAP1 mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of YAP1 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of YAP1 mRNA | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of YAP1 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of YAP1 mRNA | 20546886|2142705 |
| C551177 | vemurafenib | vemurafenib affects the localization of YAP1 protein | 26668268 |
| C551177 | vemurafenib | YAP1 protein mutant form results in decreased susceptibility to vemurafenib | 26668268 |
| C551177 | vemurafenib | [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased expression of MYC protein] | 26668268 |
| C551177 | vemurafenib | [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased phosphorylation of MAPK1 protein] | 26668268 |
| C551177 | vemurafenib | [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased phosphorylation of MAPK3 protein] | 26668268 |
| C009687 | wortmannin | wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form] | 21214929 |
| C009687 | wortmannin | wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form] | 21214929 |
| D015032 | Zinc | [PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA | 18593933 |